Nuprin 75mg gastro-resistant tablets

Država: Irska

Jezik: engleski

Izvor: HPRA (Health Products Regulatory Authority)

Aktivni sastojci:

Acetylsalicylic acid

Dostupno od:

Actavis Group PTC ehf

ATC koda:

B01AC; B01AC06

INN (International ime):

Acetylsalicylic acid

Doziranje:

75 milligram(s)

Farmaceutski oblik:

Gastro-resistant tablet

Tip recepta:

Product subject to prescription which may be renewed (B)

Područje terapije:

Platelet aggregation inhibitors excl. heparin; acetylsalicylic acid

Status autorizacije:

Marketed

Datum autorizacije:

2011-07-15

Uputa o lijeku

* Please note that ONLY Artwork Studio is permitted to make changes to
the above artwork.
No changes are permitted by any 3rd party other than added notes and
mark ups for required changes.
approved for print/date
PROOF ROUND
[e-mail]
Technical
Approval
NON PRINTING COLOURS
COLOURS
DATE SENT:
DATE RECEIVED:
Item number:
ORIGINATOR:
ORIGINATION DATE:
REVISION DATE:
REVISED BY:
DIMENSIONS:
MIN BODY TEXT SIZE:
SUPPLIER:
1.
2.
3.
4.
5.
6.
1.
2.
3.
FMD info
NA (not a carton)
£
No
£
Yes
£
Details
ACETYLSALICYLIC ACID ALL STRENGTHS GASTRO-RESISTANT TABLETS PIL FOR
BLISTERS - IRELAND
Black
BBBA5012
T. Hull
29.05.2019
190 x 600
12pt
Teva Bulgaria Dupnitsa
29.05.2019
29.05.2019
1
Version 2
01.11.2017
NUPRIN 75 MG GASTRO-RESISTANT TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it
again.
• If you have any further questions, ask your
doctor or pharmacist.
• This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the
same as yours.
• If you get any side effects, talk to your doctor
or pharmacist. This includes any possible
side effects not listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET:
1
WHAT NUPRIN IS AND WHAT IT IS USED FOR
2
WHAT YOU NEED TO KNOW BEFORE YOU
TAKE NUPRIN
3
HOW TO TAKE NUPRIN
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE NUPRIN
6
CONTENTS OF THE PACK AND OTHER
INFORMATION
1
WHAT NUPRIN IS AND WHAT IT IS USED FOR
Nuprin contains acetylsalicylic acid, which in
low doses belong to a group of medicines called
anti-platelet agents. Platelets are tiny cells in
the blood that cause the blood to clot and are
involved in thrombosis. When a blood clot occurs
in an artery it stops the blood flowing and cuts
off the oxygen supply. When this happens in the
heart it can cause a heart attack or angina; in the
brain it can cause a stroke.
Nuprin is taken to reduce the ris

Svojstava lijeka

Health Products Regulatory Authority
15 October 2019
CRN0093DH
Page 1 of 10
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Nuprin 75mg gastro-resistant tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gastro-resistant tablet contains 75mg acetylsalicylic acid
(aspirin).
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Gastro-resistant tablet.
75 mg: Oval, white, biconvex film-coated tablets, 9.2 x 5.2 mm.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
- Secondary prevention of myocardial infarction.
- Prevention of cardiovascular morbidity in patients suffering from
stable angina pectoris.
- History of unstable angina pectoris, except during the acute phase.
- Prevention of graft occlusion after Coronary Artery Bypass Grafting
(CABG).
- Coronary angioplasty, except during the acute phase.
- Secondary prevention of transient ischaemic attacks (TIA) and
ischaemic cerebrovascular accidents (CVA), provided
intracerebral haemorrhages have been ruled out.
Nuprin is not recommended in emergency situations. It is restricted to
secondary prevention with chronic treatment.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Adults
_Secondary prevention of myocardial infarction:_
The recommended dose is 75-160 mg once daily.
_Prevention of cardiovascular morbidity in patients suffering from
stable angina pectoris:_
The recommended dose is 75-160 mg once daily.
_History of unstable angina pectoris, except during the acute phase:_
The recommended dose is 75-160 mg once daily.
_Prevention of graft occlusion after Coronary Artery Bypass Grafting
(CABG):_
The recommended dose is 75-160 mg once daily.
_Coronary angioplasty, except during the acute phase:_
The recommended dose is 75-160 mg once daily.
_Secondary prevention of transient ischaemic attacks (TIA) and
ischaemic cerebrovascular accidents (CVA), provided intracerebral _
_haemorrhages have been ruled out:_
The recommended dose is 75-325 mg once daily.
Elderly
Health Products Regulatory Authority
15 October 2019
CRN0093DH
Page 2